Valuation: Merck & Co., Inc.

Market Cap 315B 275B 254B 234B 441B 30,326B 451B 3,035B 1,194B 14,852B 1,183B 1,157B 51,129B P/E 2026 *
64.9x
P/E 2027 * 15.5x
Enterprise Value 351B 307B 283B 261B 491B 33,782B 502B 3,381B 1,330B 16,545B 1,317B 1,289B 56,956B EV / Sales 2026 *
5.24x
EV / Sales 2027 * 4.83x
Free-Float
69%
Yield 2026 *
2.66%
Yield 2027 * 2.73%
1 day-0.10%
1 week+3.21%
Current month-0.78%
1 month+11.97%
3 months+7.08%
6 months+17.16%
Current year+21.13%
1 week 120.16
Extreme 120.16
131.74
1 month 113
Extreme 112.995
131.74
Current year 104.43
Extreme 104.43
131.74
1 year 76.66
Extreme 76.66
131.74
3 years 73.31
Extreme 73.31
134.63
5 years 70.89
Extreme 70.89
134.63
10 years 52.83
Extreme 52.83
134.63
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2021
Director of Finance/CFO 57 01/04/2021
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 65 27/11/2007
Director/Board Member 73 01/09/1995
Chairman 59 01/12/2022
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Other

Director

126 0.0000%
30/6/26 Other

Director

63 0.0000%
30/6/26 Other

Director

233 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%+3.21%+59.45%+20.34% 315B
-1.20%-2.43%+23.24%-8.31% 67.81B
+0.35%+2.11%+37.84%+86.59% 9.23B
+0.34%+0.51%+5.21%-0.69% 8.56B
+1.53%-3.64%-22.91%+5.31% 4.18B
-11.03%-12.07%-8.02%+14.00% 3.59B
+1.87%+3.36%-46.36%+28.62% 3.55B
-0.35%-0.87%+48.55%+60.56% 2.79B
-7.41%-2.37%+3.91%-23.64% 2.09B
-8.90%+0.76%-22.25%+27.98% 1.83B
Average -2.49%-1.27%+7.87%+21.08% 41.85B
Weighted average by Cap. -0.40%+1.03%+48.99%+16.68%

Financials

2026 *2027 *
Net sales 66.91B 58.47B 53.96B 49.74B 93.74B 6,444B 95.82B 645B 254B 3,156B 251B 246B 10,864B 70.06B 61.23B 56.5B 52.08B 98.16B 6,747B 100B 675B 266B 3,305B 263B 257B 11,376B
Net income 5.26B 4.6B 4.24B 3.91B 7.37B 506B 7.53B 50.69B 19.94B 248B 19.75B 19.32B 854B 20.1B 17.57B 16.21B 14.94B 28.17B 1,936B 28.79B 194B 76.21B 948B 75.5B 73.84B 3,264B
Net Debt 35.89B 31.37B 28.95B 26.68B 50.29B 3,457B 51.4B 346B 136B 1,693B 135B 132B 5,828B 23.2B 20.27B 18.71B 17.24B 32.5B 2,234B 33.22B 224B 87.95B 1,094B 87.13B 85.22B 3,767B
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (73.9%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (15.5%); - sale of animal health products (9.8%); - other (0.8%). Net sales are distributed geographically as follows: the United States (56.2%), Europe/Middle East/Africa (22.4%), Latin America (5.2%), Asia/Pacific (4.6%), Japan (4.2%), China (3%) and other (4.4%).
Employees
74,000
Date Price Change Volume
17/07/26 US$127.50 -0.10% 13,472,722
16/07/26 US$127.63 +3.25% 13,038,762
15/07/26 US$123.61 +2.34% 9,053,781
14/07/26 US$120.78 -2.62% 9,932,947
13/07/26 US$124.03 +0.40% 5,225,798
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
127.50USD
Average target price
134.04USD
Spread / Average Target
+5.13%

Quarterly revenue - Rate of surprise